{"id": "1351536205914124289", "creation": 1611066316.0, "user_id": "1304113315233370118", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet https://t.co/RqnNYLpiBE \n#COVID19  #vaccines #vaccine", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINES", "#VACCINE"]}